Terms: = Cervical cancer AND MUC16, CA125, CA-125 AND Diagnosis
104 results:
1. cervical clear cell carcinoma: Case report and literature review.
Su D; Song X; Wu F; Fan S; Li M
Medicine (Baltimore); 2024 Mar; 103(13):e37449. PubMed ID: 38552088
[TBL] [Abstract] [Full Text] [Related]
2. Serum expression of tumor marker CA242 in patients with different gynecological diseases.
Zhu J; Li H
Lab Med; 2023 Nov; 54(6):613-617. PubMed ID: 37035887
[TBL] [Abstract] [Full Text] [Related]
3. Highly expressed circ_0000285 from serum and cervical exfoliated cells as a novel biomarker for the diagnosis of early stage-cervical cancer.
Chen H; Tian X; Luan Y; Lu H
J Obstet Gynaecol; 2023 Dec; 43(1):2196344. PubMed ID: 37029728
[TBL] [Abstract] [Full Text] [Related]
4. Laparoscopic Management of Disseminated Peritoneal Leiomyomatosis.
Kriplani I; Kriplani A; Sharma S; Sodhi M; Jain N
J Minim Invasive Gynecol; 2023 Jun; 30(6):443-444. PubMed ID: 36934877
[TBL] [Abstract] [Full Text] [Related]
5. Value of TCT combined with HPV and ca125 in early cervical cancer screening in a medical examination population.
Xiao M; Zhang Z; Yu X; Fan Y; Chen X
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(9):160-164. PubMed ID: 36905257
[TBL] [Abstract] [Full Text] [Related]
6. Current and emerging biomarkers in ovarian cancer diagnosis; ca125 and beyond.
Sharma T; Nisar S; Masoodi T; Macha MA; Uddin S; Akil AA; Pandita TK; Singh M; Bhat AA
Adv Protein Chem Struct Biol; 2023; 133():85-114. PubMed ID: 36707207
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of HE4 as a prognostic biomarker in uterine cervical cancer
Dubey H; Ranjan A; Durai J; Khan MA; Lakshmy R; Khurana S; Gupta S; Meena J; Ray MD; Tanwar P; Chopra A; Tiwari S
Cancer Treat Res Commun; 2023; 34():100672. PubMed ID: 36525756
[TBL] [Abstract] [Full Text] [Related]
8. Pathways to diagnosis of endometrial and ovarian cancer in the 45 and Up Study cohort.
Yap S; Vassallo A; Goldsbury D; O'Connell DL; Brand A; Emery J; DeFazio A; Canfell K; Steinberg J
Cancer Causes Control; 2023 Jan; 34(1):47-58. PubMed ID: 36209449
[TBL] [Abstract] [Full Text] [Related]
9. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
10. Antibodies as biomarkers for cancer risk: a systematic review.
Monroy-Iglesias MJ; Crescioli S; Beckmann K; Le N; Karagiannis SN; Van Hemelrijck M; Santaolalla A
Clin Exp Immunol; 2022 Jul; 209(1):46-63. PubMed ID: 35380164
[TBL] [Abstract] [Full Text] [Related]
11. Fallopian tube tumour presenting as supraclavicular lymph node metastasis.
Moleiro ML; Veloso H; Brás RD; Gouveia A
BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35210227
[TBL] [Abstract] [Full Text] [Related]
12. Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer.
Cao X; Yao J; Jia M; Shen X; Zhang J; Ju S
J Ovarian Res; 2022 Feb; 15(1):20. PubMed ID: 35115025
[TBL] [Abstract] [Full Text] [Related]
13. Clinical value of MRI, serum SCCA, and ca125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer.
Ran C; Sun J; Qu Y; Long N
World J Surg Oncol; 2021 Dec; 19(1):343. PubMed ID: 34886853
[TBL] [Abstract] [Full Text] [Related]
14. Significance of serum ca125 level in surgically resected cervical adenocarcinoma with adverse features.
Kim N; Park W; Cho WK; Bae DS; Kim BG; Lee JW; Choi CH; Kim TJ; Lee YY
J Gynecol Oncol; 2021 Sep; 32(5):e72. PubMed ID: 34132070
[TBL] [Abstract] [Full Text] [Related]
15. The Adler grade by Doppler ultrasound is associated with clinical pathology of cervical cancer: Implication for clinical management.
Che D; Yang Z; Wei H; Wang X; Gao J
PLoS One; 2020; 15(8):e0236725. PubMed ID: 32777812
[TBL] [Abstract] [Full Text] [Related]
16. Diagnostic Value of Albumin to Fibrinogen Ratio in cervical cancer.
Huang L; Mo Z; Zhang L; Qin S; Qin S; Li S
Int J Biol Markers; 2020 Jun; 35(2):66-73. PubMed ID: 32389031
[TBL] [Abstract] [Full Text] [Related]
17. Circulating tumor cells in gynaecological malignancies.
Kiss I; Kolostova K; Pawlak I; Bobek V
J BUON; 2020; 25(1):40-50. PubMed ID: 32277613
[TBL] [Abstract] [Full Text] [Related]
18. Gynecologic cancer in pregnancy.
Korenaga TK; Tewari KS
Gynecol Oncol; 2020 Jun; 157(3):799-809. PubMed ID: 32268951
[TBL] [Abstract] [Full Text] [Related]
19. Ten years of experience with endometrial cancer treatment in a single Brazilian institution: Patient characteristics and outcomes.
Anton C; Kleine RT; Mayerhoff E; Diz MDPE; Freitas D; Carvalho HA; Carvalho JPM; Silva ASE; Genta MLND; Silva ALFE; Salim RC; Aranha A; Lopez RVM; Carvalho FM; Baracat EC; Carvalho JP
PLoS One; 2020; 15(3):e0229543. PubMed ID: 32134921
[TBL] [Abstract] [Full Text] [Related]
20. The potential of ciRS-7 for predicting onset and prognosis of cervical cancer.
Zhou Y; Shen L; Wang YZ; Zhou CC
Neoplasma; 2020 Mar; 67(2):312-322. PubMed ID: 31884800
[TBL] [Abstract] [Full Text] [Related]
[Next]
